Health Affairs September 6, 2017
Editor’s note: One of the authors of this post, Peter Neumann, will be discussing issues related to the post at a Health Affairs September 13 event, “Understanding The Value of Innovations In Medicine.”
In 1996, the U.S. Panel on Cost-Effectiveness in Health and Medicine recommended that analysts conducting cost-effectiveness analyses (CEAs) should perform a reference case analysis, following a set of standard methodological practices to improve comparability and quality. They further recommended that such analyses assume a societal perspective, reflecting the perspective of a decision maker allocating resources broadly across the entire population (such as consequences of interventions that fall outside the health sector).
Since publication of the original Panel’s report, researchers have published thousands of CEAs. However, as highlighted...
Today's Sponsors
Today's Sponsor